v3.26.1
STOCKHOLDERS' EQUITY - Schedule of Non-Vested Share Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Grant Date Weighted Average Fair Value (per share)      
Granted (in usd per share) $ 11,765 $ 20,766 $ 480
Number of shares converted from RSU (in share) 1    
Percentage of convertible RSU payable in stock 50.00%    
Percentage of convertible RSU payable in cash 50.00%    
Restricted Stock | Restricted Stock Grants (2022 Plan)      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, [Roll Forward]      
Beginning balance (in shares) 39,409 73,059 66,667
Granted (in shares) 67,323 39,409 73,059
Vested (in shares) (49,261) (73,059) (66,667)
Forfeited (in shares) 0 0 0
Ending balance (in shares) 57,471 39,409 73,059
Restricted Stock Units (RSUs) | Restricted Stock Units (Manager Plan)      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, [Roll Forward]      
Beginning balance (in shares) 2,611,361 0 0
Granted (in shares) 2,186,565 3,370,474 0
Vested (in shares) (1,123,491) (759,113) 0
Forfeited (in shares) 0 0 0
Ending balance (in shares) 3,674,435 2,611,361 0